GH Research PLC (NASDAQ: GHRS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT GH RESEARCH PLC

GH Research PLC (NASDAQ: GHRS)
Listen to this Section


$22.16
-1.0900 ( -4.69% ) 119.8K

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

Market Data


Open $22.16
Previous Close $23.25
Volume 119.8K
Market Cap $1.68B
Day Range $22.04 - $23.75
52 Week Range $11.32 - $25.94
Shares Outstanding 68.61M
Change % -4.69%
Net Change ▼ -1.0900
Insider Ownership N/A
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 1 Aug 01, 2025
20-f/a Annual reports 111 Jul 29, 2025
6-k Form 6-K 23 Jul 23, 2025
6-k Form 6-K 2 Jun 20, 2025
6-k Form 6-K 27 Jun 18, 2025
6-k Form 6-K 1 Jun 13, 2025

Latest News


× Before browsing our site, please accept our cookies policy